The eye is considered to be a critical organ when determining safety standards for radiofrequency radiation. With a detailed anatomy of the human eye and orbit inserted in a whole-head model, the specific absorption rates (SARs) and thermal effects were determined under exposure to a dipole antenna representing a mobile phone operating at 900, 1500 and 1800 MHz with an output power of 1 W. The temperature rise was calculated by taking the blood flow into account either by the Pennes bioheat model or by including the discrete vasculature (DIVA). In addition, a simple spherical model using constant heat transfer coefficients was used. Peak SARs in the humour are 4.5, 7.7 and 8.4 W kg(-1) for 900, 1500 and 1800 MHz respectively. Averaged over the whole eyeball, the SARs are 1.7, 2.5 and 2.2 W kg(-1). The maximum temperature rises in the eye due to the exposure are 0.22, 0.27 and 0.25 degrees C for exposure of 900, 1500 and 1800 MHz, respectively, calculated with DIVA. For the Pennes bioheat model, the temperature rises are slightly lower: 0.19, 0.24, 0.22 degrees C respectively. For the simple spherical model, the maximum temperature rises are 0.15, 0.22 and 0.20 degrees C. The peak temperature is located in the anterior part of the lens for 900 MHz and deeper in the eye for higher frequencies, and in the posterior part of the lens for 1500 MHz and close to the centre of the eyeball for 1800 MHz. For these RF safety applications, both DIVA and the Pennes bioheat model could be used to relate the SAR distributions to the resulting temperature distributions. Even though, for these artificial exposure conditions, the SAR values are not in compliance with safety guidelines, the maximum temperature rises in the eye are too small to give harmful effects. The temperature in the eye also remains below body core temperature.
The practical use of a discrete vessel thermal model for hyperthermia treatment planning requires a number of choices with respect to the unknown part of the patient's vasculature. This work presents a study of the thermal effects of blood flow in a simple tissue geometry with a detailed artificial vessel network. The simulations presented here demonstrate that an incomplete discrete description of the detailed network results in a better prediction of the temperature distribution than is obtained using the conventional bio-heatsink equation. Therefore, efforts to obtain information on the positions of the large vessels in an individual hyperthermia patient will be rewarded with a more accurate prediction of the temperature distribution.
Purpose: Treatment plans for the MR‐linac, calculated in Monaco v5.19, include direct simulation of the effects of the 1.5T B0‐field. We tested the feasibility of using a collapsed‐cone (CC) algorithm in Oncentra, which does not account for effects of the B0‐field, as a fast online, independent 3D check of dose calculations. Methods: Treatment plans for six patients were generated in Monaco with a 6 MV FFF beam and the B0‐field. All plans were recalculated with a CC model of the same beam. Plans for the same patients were also generated in Monaco without the B0‐field. The mean dose (Dmean) and doses to 10% (D10%) and 90% (D90%) of the volume were determined, as percentages of the prescribed dose, for target volumes and OARs in each calculated dose distribution. Student's t‐tests between paired parameters from Monaco plans and corresponding CC calculations were performed. Results: Figure 1 shows an example of the difference between dose distributions calculated in Monaco, with the B0‐field, and the CC algorithm. Figure 2 shows distributions of (absolute) difference between parameters for Monaco plans, with the B0‐field, and CC calculations. The Dmean and D90% values for the CTVs and PTVs were significantly different, but differences in dose distributions arose predominantly at the edges of the target volumes. Inclusion of the B0‐field had little effect on agreement of the Dmean values, as illustrated by Figure 3, nor on agreement of the D10% and D90% values. Conclusion: Dose distributions recalculated with a CC algorithm show good agreement with those calculated with Monaco, for plans both with and without the B0‐field, indicating that the CC algorithm could be used to check online treatment planning for the MRlinac. Agreement for a wider range of treatment sites, and the feasibility of using the γ‐test as a simple pass/fail criterion, will be investigated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.